Equillium Analyst Price Targets - Benzinga

Equillium Inc

EQNASDAQ

Trade with Public

Trade with Public

$2.41

At close: Sep 9, 5:00 PM EST

$2.41

N/A

After Hours: 5:30 PM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Equillium Analyst Price Targets

Wall Street analyst price targets and consensus rating for Equillium (EQ).

Price Target Range — 7 Quarters

Analyst Consensus — 7 Analysts

1S.Buy

5Buy

1Hold

Consensus RatingBuy# Analysts7Avg. Consensus PT$9Upside to Avg. PT+280.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 4, 2026	Roth Capital	Adam Walsh	Maintained	Buy	$12
Jul 13, 2026	Piper Sandler	Yasmeen Rahimi	Initiate	Overweight	$20
Jun 2, 2026	Roth Capital	Adam Walsh	Maintained	Buy	$12
May 28, 2026	Leerink Partners	Thomas Smith	Upgrade	Market Perform→Outperform	$1→$6
May 28, 2026	Roth Capital	Adam Walsh	Maintained	Buy	$12
Apr 17, 2026	Roth Capital	Adam Walsh	Maintained	Buy	$12
Apr 16, 2026	B. Riley Securities	William Woods	Initiate	Buy	$6
Apr 14, 2026	Raymond James	Martin Auster	Initiate	Strong Buy	$6
Mar 13, 2026	Roth Capital	Adam Walsh	Initiate	Buy	$12
Mar 28, 2025	Leerink Partners	Thomas Smith	Downgrade	Outperform→Market Perform	$3→$1
Nov 1, 2024	Jones Trading	Catherine Novack	Downgrade	Buy→Hold	—
Aug 19, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$5
Jun 5, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$5
May 17, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$5
Apr 2, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$4→$5
Dec 26, 2023	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$5→$4
Nov 13, 2023	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$6→$5

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Roth Capital Reiterates Buy on Equillium, Maintains $12 Price Target

Roth Capital analyst Adam Walsh reiterates Equillium (NASDAQ:EQ) with a Buy and maintains $12 price target.

Benzinga Newsdesk

PRO
Piper Sandler Initiates Coverage On Equillium with Overweight Rating, Announces Price Target of $20

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Equillium (NASDAQ:EQ) with a Overweight rating and announces Price Target of $20.

Benzinga Newsdesk

PRO
Roth Capital Reiterates Buy on Equillium, Maintains $12 Price Target

Roth Capital analyst Adam Walsh reiterates Equillium (NASDAQ:EQ) with a Buy and maintains $12 price target.

Benzinga Newsdesk

PRO
Leerink Partners Upgrades Equillium to Outperform, Raises Price Target to $6

Leerink Partners analyst Thomas Smith upgrades Equillium (NASDAQ:EQ) from Market Perform to Outperform and raises the price target from $1 to $6.

Benzinga Newsdesk

PRO
Roth Capital Reiterates Buy on Equillium, Maintains $12 Price Target

Roth Capital analyst Adam Walsh reiterates Equillium (NASDAQ:EQ) with a Buy and maintains $12 price target.

Benzinga Newsdesk

PRO
Roth Capital Reiterates Buy on Equillium, Maintains $12 Price Target

Roth Capital analyst Adam Walsh reiterates Equillium (NASDAQ:EQ) with a Buy and maintains $12 price target.

Benzinga Newsdesk